|Date:||27 June 2013|
|Subject:||MHRA nets UK record £12.2 million haul of counterfeit and unlicensed medicines|
|Contact:||Press Office 020 3080 7651
Out-of-hours 07770 446 189
The MHRA today announced that it seized a record £12.2 million of counterfeit and unlicensed medicines in the UK. This was part of a week-long international crackdown on the illegal internet trade of medicines that seized over £26.8 million globally.
The crackdown – called Operation Pangea VI - was conducted between 18 June and 25 June and resulted in 58 people being arrested worldwide. This operation has also resulted in 9, 610 illegal online websites that were selling counterfeit and unlicensed medicines being closed down or suspended through domain name or payment facility removal.
Coordinated by INTERPOL and carried out by 99 countries across the globe, the operation targeted the three main elements misused in the illegal website trade – the internet infrastructure, the electronic payment system and the mail delivery service.
Internationally, preliminary results show that more than 522,000 packages were inspected by regulators and customs officials resulting in the seizure of over £9.9 million doses of unlicensed and counterfeit medicines worth approximately £26.8 million.
In the United Kingdom, enforcement officers from the MHRA, with assistance from the Home Office UK Border Force and local police, raided addresses in connection with the illegal internet supply of medicines.
This activity resulted in more than 3.7 million doses of unlicensed medicines worth approximately £12.2 million, including 97,500 doses of counterfeit pills being seized in the UK worth £525,000. The types of medicines the MHRA found were those for slimming, hair loss and erectile dysfunction.
The MHRA’s Acting Head of Enforcement, Nimo Ahmed, said: “During one week we have seized £12.2 million worth of counterfeit and unlicensed medicines. These were being stored in unacceptable conditions and supplied through illegal internet websites without prescriptions by people who are not qualified to dispense medicines.
“When people buy medicines from an illegal website they don’t know what they’re getting, where it came from or if it’s safe to take. The dose could be too high or too low, or the ingredients could break down incorrectly in the body which makes the medicine ineffective. They could also become victims of credit card or identity fraud as well as downloading computer viruses.
“We have closed down 1288 of these illegal websites but people need to take the time to see their GP about any problems they have with their health. People are far more likely to get better faster if they are on the correct course of safely prescribed medication.”
This year’s closure of illegal websites follows on from last year when approximately 18,000 illegal pharmacy websites were shut down through domain name or payment facility removal.
A representative from Home Office UK Border force said: “The work carried out by Border Force officers as part of this joint operation makes clear just how seriously we take the smuggling of fake and unlicensed medicines.
“Smugglers are only out to make a profit. These goods are often dangerous and the proceeds can be used to fund serious organised crime.”
The Royal Pharmaceutical Society’s Neal Patel, said: “It is hugely worrying that prescription medicines are available from illicit websites. This is a serious patient safety issue.
“Not only is supplying prescription only medicines without a prescription illegal, it means that the user has no information about the ingredients, dosage instructions, or potential side effects, so patients would not be receiving proper healthcare advice.
“We would urge the public if they wish to buy medicines online to always check that they are dealing with a genuine pharmacy.”
If someone suspects their medicine may be counterfeit, contact the MHRA’s designated 24-hour anti-counterfeiting hotline on 020 3080 6701 or email@example.com.
Notes to Editor
- Types of medicines seized include analgesic/pain relief, acne, narcolepsy, anti-anxiety, breast cancer, erectile dysfunction / premature ejaculation, weight-loss, antibiotics, anti-histamines, anti-viral, asthma, arthritis, breast cancer, diabets, epilepsy medicine, eye drops, anti-Eczema / skin lightening, anti-cholesterol, anabolic steroids, contact lenses, human growth hormones, anti-depressants, psychoactive drugs, anti-abortion, skin tanning, Parkinson medicine, weight loss, fertility drugs, renal failure.
- Operation Pangea is an international initiative to target the illegal internet trade in pharmaceutical products. It was instigated by the MHRA in April 2006 and started as the UK Internet Day of Action (IDA). In 2008 this was broadened to an International Day of Action (Op Pangea I) involving eight countries. 2009 saw the initiative expand to an International Week of Action (Op Pangea II) involving 25 countries coordinated by INTERPOL. There were 45 countries that participated in the 2010 operation, 85 in 2011, 100 in 2012 and 99 in this year’s operation.
- The operation is the largest internet based enforcement action of its kind to date and involves INTERPOL, the World Customs Organisation (WCO), the Permanent Forum of International Pharmaceutical Crime (PFIPC) and the Heads of Medicines Agencies Working Group of Enforcement Officers (HMA WGEO) and the Center for Safe Internet Pharmacies (CSIP).
- People should take prescription only medicine in consultation with their GP or other healthcare professionals. These people have access to patient health records and can take into account the risks and benefits associated with every medicine as well as providing ongoing monitoring of the treatment.
- Further information about purchasing medicines safely online can be found at the following MHRA website link: Counterfeit medicines and devices
- The General Pharmaceutical Council operates an internet pharmacy logo to help the public identify if a website is being operated by a bona fide pharmacy in Great Britain.
- The MHRA is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks. We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. We encourage everyone – the public and healthcare professionals as well as the industry – to tell us about any problems with a medicine or medical device, to enable us to investigate and take any necessary action.